Cees B. de Vos

Cees B. de Vos

Auto-generated profile, based on publicly available information

Cees B. de Vos

Department of Cardiology, Laurentius Hospital, Roermond, Netherlands

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2012 in Aging Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
SFStefano Fumagalli
Stefano Fumagalli
RNRobby Nieuwlaat
Robby Nieuwlaat
FTFrancesca Tarantini
Francesca Tarantini
CVCees B. de Vos
Cees B. de Vos
CWChrist J. Werter
Christ J. Werter
HCHarry J. G. M. Crijns
Harry J. G. M. Crijns

23 November 2009 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
CVCees B. DE Vos
Cees B. DE Vos
LPLaurent Pison
Laurent Pison
RPRon Pisters
Ron Pisters
USUlrich Schotten
Ulrich Schotten
ECEmile C. Cheriex
Emile C. Cheriex
RTRobert G. Tieleman
Robert G. Tieleman

8 May 2012
Verified
Journal Article
Closed access
SFStefano Fumagalli
Stefano Fumagalli
RNRobby Nieuwlaat
Robby Nieuwlaat
FTFrancesca Tarantini
Francesca Tarantini
CVCees B De Vos
Cees B De Vos
CWChrist J Werter
Christ J Werter
HCHarry J G M Crijns
Harry J G M Crijns
Atrial fibrillation (AF) is the most frequent sustained arrhythmia of elderly patients, in whom it determines an increase in morbidity and mortality. Aim of this study was to assess age-related differences in the characteristics, management and prognosis of patients with AF in European cardiology practices. The Euro Heart Survey on AF was an observational study sponsored by the European Society of Cardiology. Patients were enrolled between 2003 and 2004 in 182 hospitals of 35 countries. For the purposes of this study, they were categorized into three age-groups: 80 years (n=671). Follow-up was closed in 2005. Compared with general population estimates, patients >80 years were underrepresented in the Euro Heart Survey. The oldest patients were less likely to be enrolled by university or specialized centers, to receive extensive diagnostic testing, and to receive oral anticoagulation despite a worse stroke risk profile. Furthermore, the oldest patients less often received rhythm control therapy, even when presenting with palpitations and non-permanent AF. During 1 year follow-up, elderly patients more often suffered a myocardial infarction, new onset heart failure and major bleedings. They had higher all-cause and cardiovascular mortality. Elderly patients with AF are less often referred to the cardiologist and, based on current guidelines, are inadequately studied and treated, compared to younger counterparts. Education on evidence- based management and the design of randomized controlled trials specifically targeting the elderly, should improve the management and prognosis of this frail segment of the AF population.

24 September 2009 in EP Europace
Verified
Journal Article
Open access
PDF file
RPRon Pisters
Ron Pisters
CVCees B. de Vos
Cees B. de Vos
RDRobert Dennert
Robert Dennert
HCHarry J. Crijns
Harry J. Crijns
Chronic heart failure (CHF) is frequently accompanied by atrial fibrillation (AF). How often AF occurs in CHF patients is difficult to know since many episodes come and go undetected because of lacking symptoms. Therefore, assessing the total burden of AF calls for continuous rhythm monitoring. At present, we do not know whether assessing burden of AF is clinically relevant. Furthermore, we do not know whether AF has any impact on survival in CHF patients, since previous clinical studies show conflicting results.

20 December 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
LFLisa D S Frenk
Lisa D S Frenk
BRBraim Rahel
Braim Rahel
CVCees B de Vos
Cees B de Vos
FOFrits Van Osch
Frits Van Osch
FPFabiana G Prestigiacomo
Fabiana G Prestigiacomo
JMJoan G Meeder
Joan G Meeder
Introduction Ischaemic heart disease is the single most common cause of death worldwide. Traditionally, distinguishing patients with cardiac ischaemia from patients with less alarming disease, in prehospital triage of chest pain, is challenging for both general practitioners and ambulance paramedics. Less than 20% of patients with chest pain, transferred to the emergency department (ED), have an acute coronary syndrome (ACS) and the transportation and analysis at the ED of non-ACS patients result in substantial healthcare costs and a great patient burden. Advanced risk stratification, with the help of cardiac troponin measurements, seems crucial to improve prehospital diagnostic accuracy. Methods and analysis The URGENT 2.0 trial is a randomised controlled trial in which the primary objective is to reduce the referral of non-cardiac chest pain (NCCP) patients, using a modified HEART score including a high-sensitivity capillary point-of-care high-sensitivity cardiac troponin I measurement. Patients are included by ambulance paramedics and 1:1 randomised for (1) regular care (control group) or (2) modified HEART score analysis (intervention group) and non-referral in case of a low modified HEART score (0–3). In total, 852 patients will be included. Follow-up will be performed at 30 days, 6 months and 12 months. Both referral rates of NCCP patients and the occurrence of major adverse cardiac events are defined as primary outcome measures. Ethics and dissemination The medical ethics committee Zuyderland-Zuyd Hogeschool (Netherlands) has approved this trial (reference numbers NL71820.096.19 and METCZ20190139). Written informed consent will be obtained from all participating patients. The results of this trial will be disseminated in one main paper and in additional papers with subgroup analyses. Trial registration ClinicalTrials.gov, NCT04904107.

18 October 2013
Verified
Book Chapter
Closed access
PDF file
CVC.B. de Vos
C.B. de Vos
HCH.J.G.M. Crijns
H.J.G.M. Crijns